3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Interventions
Topotecan
2
Drug Therapy
2
sintilimab
1
dinutuximab
1
atezolizumab
1
Temozolomide
1
SR 48692
1
Rabeprazole
1
Irinotecan
1
Etoposide
1
Electroporation
1
EC regimen
1
E-3810
1
Cryosurgery
1
Carboplatin
1
Bevacizumab
1
2,2',4,4',5-pentachlorodiphenyl ether
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Small Cell Lung Carcinoma
×
SR 48692
×
Clear all
NCT00290953
2008-12-23
SESAME
Sanofi
Phase 2/3
Completed
432 enrolled